跳至主要内容
临床试验/CTRI/2023/10/058899
CTRI/2023/10/058899尚未招募2 期

A Comparative Clinical Evaluation Of The Efficacy Of Pathoora Thylam (Nasiyam) And Regular OPD Medicine For The Treatment Of Neer Peenisam (Sinusitis)-A Pilot Study

未提供1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年10月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
20
试验地点
1
主要终点
Significant reduction in clinical symptoms of Neer peenisam by Adelaide Disease Severity Score .

研究概览

简要总结

The Present study is single arm clinical trial to assess the efficacy of Pathoora thylam(Nasiyam) for the  treatment of Neer Peenisam.In this trial 20 Patients will be recruited and the trial drug is administered externally through nostrils(3 drops)  for once in 4 days.Primary Outcome will be assessed by the efficacy of Pathoora thylam for the reduction in clinical symptoms by Adelaide Disease Severity Score and the secondary outcome by observe changes in clinical lab parameters-TC,DC,ESR,AEC and IgE pre and post treatment.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Not Applicable

入排标准

年龄范围
12.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients who were willing to give informed consent.
  • Present with the symptoms of Headache,sneezing,Itching in nose and eyes, nasal congestion,rhinorrhea,post nasal drip, Halitosis,Facial pain /pressure Pain and tenderness over paranasal sinuses.
  • Patients who had radiological evidence of sinusitis.

排除标准

  • Children age below 12 and above 60 years Patient who were not willing to particiate in the study will be excluded from the study Patients with other serious illness who are on medical emergencies.
  • Patients with known history of tuberculosis,HIV were excluded from the study.
  • Hepatits B&C Haemophilia & Bleeding Disorder Uncontrolled Diabetes Mellitus.

结局指标

主要结局

Significant reduction in clinical symptoms of Neer peenisam by Adelaide Disease Severity Score .

时间窗: 12 days

次要结局

  • Assessment of clinical lab parameters(2 weeks)

研究者

发起方
未提供

研究点 (1)

Loading locations...

相似试验